PhenoPath participates in numerous regional and national professional association meetings, trade shows, tumor boards and other events as featured speakers and show sponsors. In addition, PhenoPath invites nationally known speakers to speak at its conferences held in Seattle. Listed below are upcoming meetings and events.
New FDA Approvals for PD-L1/PD-1 Targeted Therapies & Introducing the Combined Positive Score (CPS); New Assays MUC4 IHC and TFE3 (Xp11) FISH; Amyloid Analysis;...Read More »
PhenoPath newsletter featuring the latest on RAS gene testing, "double-hit" B cell lymphomas, and a new marker for small cell carcinoma of the ovary.... Read More »
PhenoPath is pleased to announce the launch of extended RAS gene testing. Beginning June 5, 2017, PhenoPath will offer in-house KRAS and NRAS testing that...Read More »